Evidence map›Paper›PMID 37069967›Full record

ArticleKidney international reports2023

Acute Effects of Insulin Infusion on Kidney Hemodynamic Function in People With Type 2 Diabetes and Normal Kidney Function.

Michaël J B van Baar, Erik J M van Bommel, Daan J Touw, Max Nieuwdorp, Jaap A Joles, Merle M Krebber, Petter Bjornstad, Daniël H van Raalte

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Michaël J B van BaarDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUMC, Amsterdam, The Netherlands.
Erik J M van BommelDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUMC, Amsterdam, The Netherlands.
Daan J TouwDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.
Max NieuwdorpDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUMC, Amsterdam, The Netherlands.
Jaap A JolesDepartment of Nephrology and Hypertension, University Medical Center, Utrecht, The Netherlands.
Merle M KrebberDepartment of Nephrology and Hypertension, University Medical Center, Utrecht, The Netherlands.
Petter BjornstadDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Daniël H van RaalteDiabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, location VUMC, Amsterdam, The Netherlands.
Amsterdam University Medical Centers · NLUniversity Medical Center Utrecht · NLUniversity Medical Center Groningen · NLUniversity of Colorado Denver · US

Funding

Central Hub for Kidney Precision MedicineU24DK114886 · NIDDK · UNIVERSITY OF WASHINGTON · PI Jonathan Himmelfarb, Matthias Kretzler · 2022 to 2026
$21.1M
Unraveling the Impact of Per- and Polyfluoroalkyl Substances on Early Kidney Injury in Adolescents with Obesity and DiabetesR01DK129211 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI Petter Bjornstad · 2021 to 2026
$3.9M
Pathogenesis of kidney disease in type 1 diabetes: a modern kidney biopsy cohortR01DK132399 · NIDDK · UNIVERSITY OF WASHINGTON · PI Petter Bjornstad, Ian H de Boer · 2022 to 2026
$3.0M
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)R01HL165433 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER, NADEAU, KRISTEN JANE · 2022 to 2025
$2.4M
Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes StudyK23DK116720 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER · 2018 to 2022
$963k
Measuring metabolically active kidney tissue in autosomal dominant polycystic kidney diseaseR21DK129720 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BJORNSTAD, PETTER, GITOMER, BERENICE YOLANDE · 2021 to 2021
$242k
NHLBI NIH HHS R01 HL165433NIDDK NIH HHS K23 DK116720NIDDK NIH HHS R01 DK129211NIDDK NIH HHS R01 DK132399NIDDK NIH HHS R21 DK129720NIDDK NIH HHS U24 DK114886
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

diabetic kidney diseaseglomerular filtration rateinsulin infusionkidney hemodynamicskidney perfusionrenal vascular resistance

Identifiers

PMID37069967
PMCPMC10105053
OpenAlexW4313830100

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.